Kushal Naik MD MPH (He/Him)

Summary

• Physician–Epidemiologist with 9+ years of experience designing and delivering regulatory-grade real-world evidence (RWE) and analytics solutions across the pharmaceutical, biotech, federal health, and health tech sectors. I specialize in building AI/ML-enabled real-world data (RWD) platforms and executing observational studies that inform drug safety, medical strategy, market access, and commercialization.
  
  At ZS, I lead multimillion-dollar RWD SaaS initiatives and evidence-generation programs for global pharma clients across 10+ therapeutic areas — including cardiometabolic disease, oncology, neurology, and rare disorders. These initiatives enable Medical Affairs, HEOR, and Commercial teams to identify care gaps, model HCP influence, segment patient journeys, and predict treatment switching behavior at scale.
  
  Previously at Acumen and The SPHERE Institute, I led FDA- and CMS-facing pharmacoepidemiology studies, including research that directly informed a Boxed Warning for denosumab in advanced CKD. I began my career at Children’s Healthcare of Atlanta, leading outcomes research that contributed to national transplant guidelines.
  
  I've authored 20+ publications and abstracts which have 280+ citations; conference presentations at ASCO, AAN, AASLD, etc.; active peer-reviewer for JAMA Oncology; Familiar with tools like SAS, R, SQL, Tableau, Python (basic); Experienced with data such as Medicare, EHR, Symphony, Komodo, SDoH-linked claims.
  
  I'm passionate about integrating clinical insight, scalable analytics, and AI-driven platforms to help life sciences innovators deliver smarter, data-driven care.